Akash Ashokan

Also affiliated with Sylvester Comprehensive Cancer Center

Biochemistry, Genetics and Molecular BiologyMedicineEngineering

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “New Pathway for Cisplatin Prodrug to Utilize Metabolic Substrate Preference to Overcome Cancer Intrinsic Resistance”.

New Pathway for Cisplatin Prodrug to Utilize Metabolic Substrate Preference to Overcome Cancer Intrinsic Resistance

ACS Central Science(2023)10.1021/acscentsci.3c00286

N/A

0DataRank · unranked

25 citations

Subham Guin, Akash Ashokan, Uttara Basu, Bapurao Surnar, Katiana S. Delma +4 more

Cell-specific nanoengineering strategy to disrupt tolerogenic signaling from myeloid-derived suppressor cells and invigorate antitumor immunity in pancreatic cancer

Cancer Immunology Immunotherapy(2025)10.1007/s00262-025-04096-y

N/A

0DataRank · unranked

4 citations

Anna Bianchi, Haleh Amirian, Iago De Castro Silva, Christine I. Rafie, Bapurao Surnar +8 more